KRAS c.95A>C ;(p.Y32S)

Variant ID: 12-25398224-T-G

NM_004985.3(KRAS):c.95A>C;(p.Y32S)

This variant was identified in 5 publications

View GRCh38 version.




Publications:


Covalent inhibitor targets KRasG12C: A new paradigm for drugging the undruggable and challenges ahead.

Genes & Diseases
Li, Hui-Yu HY; Qi, Wei-Liang WL; Wang, Yu-Xiang YX; Meng, Ling-Hua LH
Publication Date: 2023-03

Variant appearance in text: KRAS: Y32S
PubMed Link: 37223497
Variant Present in the following documents:
  • Main text
View BVdb publication page



The current state of the art and future trends in RAS-targeted cancer therapies.

Nature Reviews. Clinical Oncology
Punekar, Salman R SR; Velcheti, Vamsidhar V; Neel, Benjamin G BG; Wong, Kwok-Kin KK
Publication Date: 2022-10

Variant appearance in text: KRAS: Y32S
PubMed Link: 36028717
Variant Present in the following documents:
  • Main text
  • 41571_2022_Article_671.pdf
View BVdb publication page



Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis.

Frontiers In Endocrinology
Hescheler, Daniel A DA; Riemann, Burkhard B; Hartmann, Milan J M MJM; Michel, Maximilian M; Faust, Michael M; Bruns, Christiane J CJ; Alakus, Hakan H; Chiapponi, Costanza C
Publication Date: 2021

Variant appearance in text: KRAS: Y32S
PubMed Link: 34630336
Variant Present in the following documents:
  • Table_1.xlsx, sheet 2
View BVdb publication page



Identification of targeted therapy options for gastric adenocarcinoma by comprehensive analysis of genomic data.

Gastric Cancer : Official Journal Of The International Gastric Cancer Association And The Japanese Gastric Cancer Association
Hescheler, Daniel A DA; Plum, Patrick S PS; Zander, Thomas T; Quaas, Alexander A; Korenkov, Michael M; Gassa, Asmae A; Michel, Maximilian M; Bruns, Christiane J CJ; Alakus, Hakan H
Publication Date: 2020-07

Variant appearance in text: KRAS: Y32S
PubMed Link: 32107691
Variant Present in the following documents:
  • 10120_2020_1045_MOESM1_ESM.xlsx, sheet 12
View BVdb publication page



Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism.

Science (New York, N.Y.)
Lito, Piro P; Solomon, Martha M; Li, Lian-Sheng LS; Hansen, Rasmus R; Rosen, Neal N
Publication Date: 2016-02-05

Variant appearance in text: KRAS: Y32S
PubMed Link: 26841430
Variant Present in the following documents:
  • Main text
View BVdb publication page